These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22182704)

  • 1. The SH2-domain of SHIP1 interacts with the SHIP1 C-terminus: impact on SHIP1/Ig-α interaction.
    Mukherjee O; Weingarten L; Padberg I; Pracht C; Sinha R; Hochdörfer T; Kuppig S; Backofen R; Reth M; Huber M
    Biochim Biophys Acta; 2012 Feb; 1823(2):206-14. PubMed ID: 22182704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
    Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B
    Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SH2 domain-containing inositol 5-phosphatase SHIP1 is recruited to the intracytoplasmic domain of human FcgammaRIIB and is mandatory for negative regulation of B cell activation.
    Isnardi I; Bruhns P; Bismuth G; Fridman WH; Daëron M
    Immunol Lett; 2006 Apr; 104(1-2):156-65. PubMed ID: 16406061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.
    Zhang J; Walk SF; Ravichandran KS; Garrison JC
    J Biol Chem; 2009 Jul; 284(30):20070-8. PubMed ID: 19494109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosine-based inhibition motif of Fc gammaRIIB in B cells under negative signaling.
    Muraille E; Bruhns P; Pesesse X; Daëron M; Erneux C
    Immunol Lett; 2000 Apr; 72(1):7-15. PubMed ID: 10789675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism.
    An H; Xu H; Zhang M; Zhou J; Feng T; Qian C; Qi R; Cao X
    Blood; 2005 Jun; 105(12):4685-92. PubMed ID: 15701712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SH2 domains of inositol polyphosphate 5-phosphatases SHIP1 and SHIP2 have similar ligand specificity but different binding kinetics.
    Zhang Y; Wavreille AS; Kunys AR; Pei D
    Biochemistry; 2009 Nov; 48(46):11075-83. PubMed ID: 19839650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K/AKT signaling.
    Brauer H; Strauss J; Wegner W; Müller-Tidow C; Horstmann M; Jücker M
    Cell Signal; 2012 Nov; 24(11):2095-101. PubMed ID: 22820502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct tyrosine-based motifs enable the inhibitory receptor FcgammaRIIB to cooperatively recruit the inositol phosphatases SHIP1/2 and the adapters Grb2/Grap.
    Isnardi I; Lesourne R; Bruhns P; Fridman WH; Cambier JC; Daëron M
    J Biol Chem; 2004 Dec; 279(50):51931-8. PubMed ID: 15456754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.
    Giuriato S; Pesesse X; Bodin S; Sasaki T; Viala C; Marion E; Penninger J; Schurmans S; Erneux C; Payrastre B
    Biochem J; 2003 Nov; 376(Pt 1):199-207. PubMed ID: 12885297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src homology 2 domain-containing inositol 5-phosphatase 1 mediates cell cycle arrest by FcgammaRIIB.
    Malbec O; Schmitt C; Bruhns P; Krystal G; Fridman WH; Daëron M
    J Biol Chem; 2001 Aug; 276(32):30381-91. PubMed ID: 11359765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL.
    Sattler M; Verma S; Pride YB; Salgia R; Rohrschneider LR; Griffin JD
    J Biol Chem; 2001 Jan; 276(4):2451-8. PubMed ID: 11031258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The two SH2-domain-containing inositol 5-phosphatases SHIP1 and SHIP2 are coexpressed in human T lymphocytes.
    Bruyns C; Pesesse X; Moreau C; Blero D; Erneux C
    Biol Chem; 1999; 380(7-8):969-74. PubMed ID: 10494849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insufficient phosphorylation prevents fc gamma RIIB from recruiting the SH2 domain-containing protein-tyrosine phosphatase SHP-1.
    Lesourne R; Bruhns P; Fridman WH; Daëron M
    J Biol Chem; 2001 Mar; 276(9):6327-36. PubMed ID: 11099496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
    Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
    J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer.
    Fuhler GM; Brooks R; Toms B; Iyer S; Gengo EA; Park MY; Gumbleton M; Viernes DR; Chisholm JD; Kerr WG
    Mol Med; 2012 Feb; 18(1):65-75. PubMed ID: 22033675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
    Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I
    J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A key role for the phosphorylation of Ser440 by the cyclic AMP-dependent protein kinase in regulating the activity of the Src homology 2 domain-containing Inositol 5'-phosphatase (SHIP1).
    Zhang J; Ravichandran KS; Garrison JC
    J Biol Chem; 2010 Nov; 285(45):34839-49. PubMed ID: 20810657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth.
    Séverin S; Gratacap MP; Lenain N; Alvarez L; Hollande E; Penninger JM; Gachet C; Plantavid M; Payrastre B
    J Clin Invest; 2007 Apr; 117(4):944-52. PubMed ID: 17347685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fc gamma immunoreceptor tyrosine-based inhibition motif peptide motif.
    Tridandapani S; Kelley T; Pradhan M; Cooney D; Justement LB; Coggeshall KM
    Mol Cell Biol; 1997 Aug; 17(8):4305-11. PubMed ID: 9234687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.